Cargando…
Integrative metabolomics of plasma and PBMCs identifies distinctive metabolic signatures in Behçet’s disease
BACKGROUND: Behçet’s disease (BD) is a systemic inflammatory disease that involves various organs. The clinical manifestation-based diagnosis of BD is a time-consuming process, which makes it difficult to distinguish from patients with similar symptoms. Moreover, an authentic biomarker has not been...
Autores principales: | Park, Soo Jin, Park, Mi Jin, Park, Sun, Lee, Eun-So, Lee, Do Yup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824930/ https://www.ncbi.nlm.nih.gov/pubmed/36609408 http://dx.doi.org/10.1186/s13075-022-02986-5 |
Ejemplares similares
-
Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia
por: Lee, Seung Mi, et al.
Publicado: (2020) -
Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease
por: Kim, En Hyung, et al.
Publicado: (2015) -
Alteration of the Fecal but Not Salivary Microbiome in Patients with Behçet’s Disease According to Disease Activity Shift
por: Kim, Jin Cheol, et al.
Publicado: (2021) -
Simultaneous Involvement of Nervous and Gastrointestinal Systems in Behçet's Disease
por: Lee, Jae Yeol, et al.
Publicado: (2012) -
Metabolome-Wide Reprogramming Modulated by Wnt/β-Catenin Signaling Pathway
por: Park, Soo Jin, et al.
Publicado: (2023)